LGALS3 and Alzheimer disease: Moreover, 5XFAD/Gal-3KO mice exhibited a substantial reduction of Aβ deposits, indicating that Gal-3 can serve as a regulator of AD-associated pathology (Boza-Serrano et al., 2019).